Pure Global

A Trial to Evaluate the Effects of Bifidobacterium Longum NCC3001 on Intestinal and Psychological Symptoms in Subjects With Irritable Bowel Syndrome - Trial NCT05054309

Access comprehensive clinical trial information for NCT05054309 through Pure Global AI's free database. This phase not specified trial is sponsored by Nestlé and is currently Recruiting. The study focuses on IBS - Irritable Bowel Syndrome. Target enrollment is 184 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05054309
Recruiting
dietary supplement
Trial Details
ClinicalTrials.gov • NCT05054309
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
A Trial to Evaluate the Effects of Bifidobacterium Longum NCC3001 on Intestinal and Psychological Symptoms in Subjects With Irritable Bowel Syndrome
A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of Bifidobacterium Longum NCC3001 on Intestinal and Psychological Symptoms in Subjects With Irritable Bowel Syndrome

Study Focus

Bifidobacterium longum

Interventional

dietary supplement

Sponsor & Location

Nestlé

North Bay,Sudbury,Toronto,Victoria, Canada

Timeline & Enrollment

N/A

Feb 11, 2022

Jul 31, 2023

184 participants

Primary Outcome

To evaluate the effect of Bifidobacterium Longum (BL NCC3001) on Gastrointestinal Symptoms,To evaluate the effect of Bifidobacterium Longum (BL NCC3001) on Psychological Symptoms

Summary

This is a prospective, randomized, placebo-controlled, double-blind, multi-center parallel-
 design study to evaluate the effect of BL NCC3001 in subjects with Irritable Bowel Syndrome.

ICD-10 Classifications

Irritable bowel syndrome with predominant constipation [IBS-C]
Irritable bowel syndrome
Irritable bowel syndrome with predominant diarrhoea [IBS-D]
Irritable bowel syndrome with mixed bowel habits [IBS-M]
Other and unspecified irritable bowel syndrome

Data Source

ClinicalTrials.gov

NCT05054309

Non-Device Trial